HOME > SOCIETY > SCIENCE > US FDA updates warning against widespread use of fluoroquinolones

US FDA updates warning against widespread use of fluoroquinolones

fluoroquinolone-toxicity-protestThe US Food & Drug Administration issued a warning against casual usage of fluoroquinolone antibiotics, arguably the most widely used broad-spectrum antibiotic in India.

USFDA advised that the side effects caused by the use of fluoroquinolone antibacterial drugs would outweigh the benefits for patients who have alternative treatment options.

Patients with acute sinusitis, acute bronchitis and uncomplicated urinary tract infections who have other treatment options should look at other options, the FDA said.  Fluoroquinolones should be reserved for those who do not have alternative treatment options.

In an FDA safety review, the fluoroquinolones, when used systemically, have been found to be associated with disabling and potentially permanent serious side effects occurring together, it said.

These side effects can involve the tendons, muscles, joints, nerves, and central nervous system.

Fluoroquinolones have emerged as the drug of choice for doctors treating everything from ear infection to sinusitis to serious and life-threatening infections due to their potency.

Fluoroquinolone drugs work by disrupting the DNA replication in bacteria, thus killing off their colonies and bringing infections under control.

However, due to the extreme efficiency, they tend to ‘wipe the slate clean’ when it comes to essential and often crucial bacteria that the human body needs for its proper functioning, and can often lead to a condition known as disbiosis and ‘leaky gut syndrome’.

The oral usage of flouroquinolones allegedly leads to increased permeability of the intestinal walls, which in turn leads to the alleged leakage of food particles and toxins into the blood, and via the blood to other organs. Restitution therapies include the use of probiotics to try to restore the gut flora as far as possible.

“While these drugs are effective in treating serious bacterial infections, FDA review found that both oral and injectable fluroquinolones are associated with disabling side effects involving the tendons, muscles, joints, nerves and the central nervous system. These side effects can occur hours to weeks after exposure to fluoroquinolones and may potentially be permanent,” FDA said.

The drug already has black-box warnings for it’s side effects and other warnings related to nervous damage, muscle weakness and fatigue.

A black box warning is the strictest warning put in the labeling of prescription drugs or drug products by the Food and Drug Administration (FDA) when there is reasonable evidence of an association of a serious hazard with the drug.

The fluoroquinolones which are sold in the market are velox (Moxifloxacin), Cipro (Ciprofloxacin), Factive (Gemifloxacin), Levaquin (Levofloxacin) and generic Ofloxacin.

In India, these drugs are available in their generic forms and are marketed by most big drug companies. Though not supposed to be given to children and old people, they are prescribed to kids as young as two in India.

This is not the first time FDA is warning about this anti bacterial drug. FDA previously communicated safety information associated with systemic fluoroquinolone antibacterial drugs in August 2013 and July 2008. The safety issues described in this Drug Safety Communication were also discussed at an FDA Advisory Committee meeting in November 2015.

In July, the FDA approved labelling changes for Fluoroquinolones and urged patients to consult with their health care professional immediately on experiencing any serious side effects including tendon, joint and muscle pain, a “pins and needles” tingling or pricking sensation, confusion, and hallucinations.

Health care professionals should stop systemic fluoroquinolone treatment immediately if a patient reports serious side effects, and switch to a non-fluoroquinolone antibacterial drug to complete the patient’s treatment course, it had warned.

The adverse reactions to the drugs have led to the emergence of several online help forums as well as groups of Facebook.

Follow ULTRA.news
India is the first country to reuse nuclear waste on large scale – Minister A rally to popularize nuclear power in Mumbai in 2014The Department of Atomic Energy today said that India is the first country in the world where the waste produced by nuclear power plants is being used for civilian applications.Jitendra Singh, the minister of state ove...
Nearly a quarter of all food samples tested found fake or adulterated Food Adulteration and Testing in India, FY16Over one-fifth of all food samples tested in India's government labs in the last year were found to be fake or adulterated, according to numbers compiled from various state government food testing facilities by union government's d...
Lopinavir syrup for children with HIV now available across India – Govt NACO ran out of Lopinavir stock in FebruaryMinister of health and family welfare Anupriya Patel said Lopinavir syrup, the life-saving drug given to infants and toddlers with HIV has been restocked by the National Aids Control Organization."NACO has done an emergency proc...
Cancer cases in India jump 4.5% in 2016 to 14.5 lakh The number of cancer cases in India jumped by 4.5% in 2016 to 14.51 lakh, according to the Indian Council of Medical Research or ICMR.The number implies that 1 in 930 people in India have cancer as of 2016.In 2015, the total number of cancer patients in India was estima...
Air India grounds 30 air hostesses for being overweight Air India, India's national carrier, has grounded 30 women and 4 men among its cabin crew for being overweight, the civil aviation ministry said in reply to a query.The grounded crew, however, comprises only 1% its total cabin crew strength of 3,490.Air India said it ...
Kerala government doctor goes behind the veil to teach Muslim women A government doctor in Kerala has come under criticism on social media for taking a Polio vaccination awareness class for women from behind a veil.According to local media reports, nearly 100 women participated in the thinly veiled awareness drive conducted by a medical super...
Govt of India starts crack down on low-quality medicine makers The government of India has started conducting inspections at drug manufacturing units across the country to prevent the production of low-quality drugs and medicines in India.Typically, inspections are conducted by state authorities, while central agencies largely confin...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS...
Alembic Pharmaceuticals receives FDA approval for hypertension tablets Alembic Pharmaceuticals Ltd said it received approval from the United States Food & Drug Administration for its abbreviated new drug application for Telmisartan and Amlodipine tablets for hypertension.The Telmisartan and Amlodipine Tablets are equivalent to the Twynsta ta...
Dr Reddy’s Labs launches osteoporosis drug in the US Dr Reddy's Laboratories Ltd said it launched raloxifene hydrochloride tablets --used to treat osteoporosis -- in the US market.Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharm...
Mylan and Biocon submits breast cancer drug application to USFDA Mylan N.V. and Biocon Ltd. said they submitted Mylan’s biologics license application for a proposed biosimilar Trastuzumab, to the U.S. Food and Drug Administration.Biosimilar trastuzumab is a proposed biosimilar to branded Trastuzumab, which is indicated to treat certain HER...
Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules -- a synthetic equivalent of Vitamin D.Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in t...
Almebic Pharmaceuticals receives inspection report from USFDA Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat.The FDA has the authority to inspect any establishment in whi...
Shilpa Medicare receives USFDA approval for generic bone marrow drug Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection.Azacitidine is used to treat myelodysplastic syndrome - a group of conditions in which the bone marrow produces blood cells that are misshapen and ...
FDA observations ‘primarily procedural’ – USFDA issued four observations about Cipla's manufacturing facilities in Goa after conducting an audit, the company said. Cipla has three facilities in Goa."The observations were primarily procedural in nature and the company has already responded to these observations," said...
Lupin receives FDA approval for generic Namenda XR dementia capsules Pharma Major Lupin Ltd said it received final approval from United States Food and Drug Administration for selling Memantine Hydrochloride extended-release capsules, a generic version of Allergan’s Namenda XR capsules.Namenda XR extended-release capsules are approved by the...
Suven Life Sciences gets two product patents in India and Japan Drug manufacturer Suven Life Sciences Ltd said it got two product patents in India and Japan for to a new compound for the treatment of disorders associated with Neurodegenerative diseases.The patents are valid through 2026-2032.The granted claims include a class of selec...
Marksans Pharma gets USFDA approval for sale of anti-allergy drug Marksans Pharma Limited, an Indian pharmaceutical company, said it has received approval from the USFDA for the sale sale of its Loratadine Liquid Filled Capsules 10 mg in the US market.Loratadine is an antihistamine that reduces the effects of natural chemical histamine in t...
Lincoln Pharma develops oral spray version of Ondansetron anti-nausea drug Lincoln Pharmaceuticals Ltd said it developed and launched an oral spray version of Ondansetron anti-nausea drug.Ondansetron is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy), radiation therapy and also in the prevention and treatment for n...
Aurobindo Pharma to launch HIV drug in Africa this year, gets tentative FDA nod Aurobindo Pharma Limited, a pharmaceutical manufacturing company based in Hyderabad, said it received a tentative approval for HIV drug Dolutegravir from US Food & Drug Administration.It is the first FDA approval of a generic version of Dolutegravir. Through a tie up w...
Worried about your diet? Try CSE’s new online interactive tool Centre for Science and Environment (CSE) has launched an online interactive tool to help people know about their food and dietary habits.“What we eat affects our health. But most of us do not know what we eat and how it affects our health. ´KNOW YOUR DIET´ is a first of its k...
Sharon Bio Medicines receives FDA approval for Tajola API plant Indian Pharmaceutical company Sharon bio medicine Ltd said it received the Establishment Inspection Report (EIR) from United States Food and Drug Amnistration for its manufacturing plant located at Tajola in Raigad Dist., Maharashtra.The plant, which will make Active Pharmace...
Dr Reddy’s Laboratories launches Paricalcitol injection in the US Market Dr. Reddy's Laboratories Ltd said it launched Paricalcitol Injection, a therapeutic equivalent generic version of Zemplar injection in the United States market approved by the US Food & Drug Administration (USFDA).The Zemplar brand and generic had US sales of approximatel...
Opto Circuits subsidiary enters global market with Freeway coated shunt baloon catheter Opto Circuits, a medical technology group, said its wholly owned subsidiary, Eurocor GmbH, entered the global market with their Freeway coated shunt baloon catheter.Freeway coated shuntbaloon catheter is used for arteriovenous (AV) access to help patients with end-stage renal d...
Suven Life Sciences granted patents in Canada, Europe & Hong Kong Drug manufacturer Suven Life Sciences Ltd said it got three product patents from Canada, Europe & Hong Kong corresponding to new chemical entity for the treatment of disorders associated with Neurodegenerative diseases.The patents are valid through 2030-2032.According...